Medical News

RSS

New solution to detect DNA base modifications associated with epigenetic regulation and DNA damage

Pacific Biosciences of California, Inc., today launched a new and unique solution to detect DNA base modifications associated with epigenetic regulation and DNA damage using the PacBio RS High Resolution Genetic Analyzer.

18 Jun 2012

Political cartoon: 'By The Book?'

Kaiser Health News provides a fresh take on health policy developments with "By The Book?" by Monte Wolverton.

18 Jun 2012

Major advance in development of night-time automatic control device for blood glucose levels at home

Yet another exciting breakthrough took place yesterday in the advancement and development of the ARTIFICIAL PANCREAS by specialists at Schneider Children's Medical Center of Israel.

18 Jun 2012

PAREXEL launches fully-integrated eClinical solution

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of the PAREXEL MyTrials platform, a fully-integrated eClinical solution that simplifies the clinical trial process.

From Parexel 18 Jun 2012

Health Canada approves Viveve System to improve sexual function after childbirth

Viveve, Inc., a woman's health company and pioneer in non-surgical vaginal tissue restoration, announces Health Canada has issued a Medical Device License for the Viveve System to treat laxity of the vaginal introitus (opening) after vaginal childbirth, to improve sexual function. The Viveve procedure is the first of its kind and clinical results have shown an improvement in the feeling of vaginal tightness and sexual satisfaction for women.

18 Jun 2012

Wellcome Trust awards University of Maryland $4M to accelerate development of conjugate NTS vaccine

The University of Maryland School of Medicine's Center for Vaccine Development (CVD) has received a $4 million Strategic Translation Award from the prestigious Wellcome Trust to support a collaboration with Bharat Biotech for clinical development of a new conjugate vaccine to prevent the potentially lethal infectious disease caused by invasive non-typhoidal Salmonella.

18 Jun 2012

Thermo Fisher Scientific introduces research-grade FT-IR system

Thermo Fisher Scientific Inc., the world leader in serving science, extended its leading FT-IR spectrometry platform by introducing the first research-grade FT-IR system designed for simple one-touch operation.

From Thermo Fisher Scientific Inc. 18 Jun 2012

CINJ commences enrollment in three-drug combination trial for breast cancer

Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.

18 Jun 2012

MMRGlobal, Fujitsu collaborate to offer cost-effective transition to electronic medical records

MMRGlobal, Inc. and Fujitsu Computer Products of America, Inc., the market leader in document imaging scanners, announced today a strategic alignment to assist physicians in smaller practices to efficiently digitize their medical records and comply with the Health Information Technology for Economic and Clinical Health (HITECH) Act's meaningful use requirement to provide patients timely online access to their medical records by the end of 2014.

18 Jun 2012

FDA clears LensAR Laser System for anterior capsulotomy

LensAR Inc., developer of the LensAR Laser System for cataract surgery, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the company's next-generation commercial system, for use in anterior capsulotomy, with and without laser phacofragmentation during cataract surgery.

18 Jun 2012

Dehaier, Heyer enter into three-year strategic mutual cooperation agreement

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that the Company has entered into a three-year strategic mutual cooperation agreement with HEYER Medical AG, an internationally recognized, Germany-based company specializing in state-of-the-art inhalation and anesthesia equipment, oxygen concentrators, breathing therapy equipment and connecting equipment.

18 Jun 2012

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.

18 Jun 2012

First Edition: June 18, 2012

Today's headlines include reports on the upcoming Supreme Court health law decision and the politics of health policy.

18 Jun 2012

Illumina's new patent infringement suit targets Complete Genomics' cPal read technology

Illumina (NASDAQ:ILMN) announced today that the company has filed an additional patent infringement suit against Complete Genomics, Inc. Illumina is seeking all available remedies, including injunctive relief.

From Illumina, Inc. 18 Jun 2012

Multi-year initiative to help people live longer and better

With 10,000 Americans turning 65 every day - and according to new research released today, a majority of them expect to live to nearly 90 - the celebration of older Americans is a developing trend, and more people are aspiring to live longer and better than ever before.

18 Jun 2012

Concord Medical acquires 52% equity ownership in Chang'an Hospital

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it has closed the acquisition of 52% equity ownership in Chang'an Hospital, a leading non-public general hospital located in Xi'an, Shaanxi Province.

18 Jun 2012

CMC Biologics' Bothell manufacturing and testing facilities receive cGMP compliance

CMC Biologics, a leading contract manufacturing organization (CMO) known for its technical excellence in process development and cGMP manufacture, has received a Certificate of Good Manufacturing Practice (GMP) Compliance for commercial manufacturing issued by the Medicines and Healthcare products Regulatory Agency (MHRA).

18 Jun 2012

Ambrx, Merck collaborate to develop and commercialize biotherapeutic drug conjugates

Ambrx today announced that the company has entered into a collaboration with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific protein medicinal chemistry technology.

18 Jun 2012

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Aeterna Zentaris Inc. today announced that data from two Phase 2 trials in renal cell carcinoma (RCC) for the Company's oral anticancer drug, perifosine, have been published in the June 2012 issue of Cancer, a publication of the American Cancer Society.

18 Jun 2012

Agility MLC's new design provides better dose sculpting capabilities

Requiring only a quick upgrade to their existing Elekta Synergy linear accelerator, physicians at SALK and Paracelsus Medical University began using the new Agility 160-leaf multileaf collimator (MLC), treating 33 patients on its first day. In its first month of Agility use, the center now treats 50 patients per day, comprising about 700 individual treatment sessions that have benefited from this breakthrough in cancer care.

From Elekta 18 Jun 2012

Medical News

New solution to detect DNA base modifications associated with epigenetic regulation and DNA damage

Political cartoon: 'By The Book?'

Major advance in development of night-time automatic control device for blood glucose levels at home

PAREXEL launches fully-integrated eClinical solution

Health Canada approves Viveve System to improve sexual function after childbirth

Wellcome Trust awards University of Maryland $4M to accelerate development of conjugate NTS vaccine

Thermo Fisher Scientific introduces research-grade FT-IR system

CINJ commences enrollment in three-drug combination trial for breast cancer

MMRGlobal, Fujitsu collaborate to offer cost-effective transition to electronic medical records

FDA clears LensAR Laser System for anterior capsulotomy

Dehaier, Heyer enter into three-year strategic mutual cooperation agreement

Infinity voluntarily stops saridegib Phase 2 trial for chondrosarcoma

First Edition: June 18, 2012

Illumina's new patent infringement suit targets Complete Genomics' cPal read technology

Multi-year initiative to help people live longer and better

Concord Medical acquires 52% equity ownership in Chang'an Hospital

CMC Biologics' Bothell manufacturing and testing facilities receive cGMP compliance

Ambrx, Merck collaborate to develop and commercialize biotherapeutic drug conjugates

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Agility MLC's new design provides better dose sculpting capabilities

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News